Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
MicroTech Medical (Hangzhou) Co., Ltd. Class H ( (HK:2235) ) just unveiled an announcement.
MicroTech Medical (Hangzhou) Co., Ltd. has granted a total of 3.3 million H shares, representing about 0.79% of its issued share capital (excluding treasury shares), to 51 eligible participants under a newly adopted share incentive scheme. The grantees include three directors, two supervisors and 46 core technical, marketing and management staff, with the awarded shares priced at HK$2.50 each versus a closing market price of HK$7.93 on the grant date. The shares will vest in two tranches—40% after one year and 60% after two years—subject to individual performance targets and a clawback mechanism, underscoring the company’s push to align management and key employees’ incentives with long-term corporate performance and shareholder interests.
The most recent analyst rating on (HK:2235) stock is a Hold with a HK$6.50 price target. To see the full list of analyst forecasts on MicroTech Medical (Hangzhou) Co., Ltd. Class H stock, see the HK:2235 Stock Forecast page.
More about MicroTech Medical (Hangzhou) Co., Ltd. Class H
MicroTech Medical (Hangzhou) Co., Ltd. is a Hong Kong-listed medical technology company based in China, operating through a group structure focused on developing, producing and marketing medical devices and related healthcare technologies. Its H shares are traded on the Stock Exchange of Hong Kong, and it relies on a mix of technical, marketing and management personnel to support its business growth and operations.
Average Trading Volume: 227,829
Technical Sentiment Signal: Buy
Current Market Cap: HK$3.23B
Learn more about 2235 stock on TipRanks’ Stock Analysis page.